ALKEM LABORATORIES
Back to All Ratios
|
ALKEM LABORATORIES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 215.24 | 176.56 | 110.18 | 165.98 | 158.29 |
What is the latest Cash Earnings per Share (CEPS) ratio of ALKEM LABORATORIES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 215.24 |
| Mar2024 | 176.56 |
| Mar2023 | 110.18 |
| Mar2022 | 165.98 |
| Mar2021 | 158.29 |
How is Cash Earnings per Share (CEPS) of ALKEM LABORATORIES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 215.24 | 21.91 | |
| Mar2024 | 176.56 | 60.25 | |
| Mar2023 | 110.18 | -33.62 | |
| Mar2022 | 165.98 | 4.86 | |
| Mar2021 | 158.29 | - | |
Other Financial Ratios of ALKEM LABORATORIES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹62,680.0 Cr | -2.1% | -3.9% | 13.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -3.1% | 1.6% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -1.5% | -3.4% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -4.1% | -1.2% | 40.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.5% | -0.9% | 16.8% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -5.7% | -7.8% | -13.2% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -2.1% |
-3.9% |
13.7% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses